EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High‐Frequency Mutations in TP53 , AXIN1 , CTNNB1 , and KRAS , and Polymorphisms in JAK1 Genes Among Mongolian HCC Patients

Nomin Bold iD, Khurelsukh Buyanbat iD, Ariya Enkhtuya iD, Nomin Myagmar iD, Gerelsuren Batbayar iD, Zolzaya Sandag iD, Dolgion Damdinbazar iD, Nomuun Oyunbat iD, Tuul Boldbaatar iD, Ankhbayar Enkhbaatar iD, Gan-Erdene Baatarjav iD, Taivan Nanzaddorj iD und 2 weitere

Cancer Reports · 2025

DOI: 10.1002/cnr2.70227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Nomin Bold und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology, Institute of Biology, Mongolian Academy of Sciences, Ulaanbaatar, Mongolia. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Axin Protein, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mongolian Foundation for Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mongolia has the highest incidence of liver cancer worldwide, largely driven by a high prevalence of hepatitis virus infections. Mutations in oncogenes and tumor suppressor genes provide valuable insights into the molecular mechanisms of hepatocellular carcinoma (HCC).

Aims

This study aimed to investigate the prevalence of mutations in key oncogenes and tumor suppressor genes in Mongolian HCC patients and to explore their molecular mechanisms, particularly in relation to hepatitis virus infections. Methods and Results We analyzed 55 tumor tissue samples from Mongolian HCC patients (2019–2021), identifying mutations in TP53 , CTNNB1 , AXIN1 , KRAS , and JAK1 through sequencing. Western blotting was used to assess β‐catenin and p53 protein levels. Our findings showed p53 overexpression in tumors with TP53 mutations (F270I and S362S), while mutations such as R213* and a short‐sequence deletion upstream of intron 7 produced premature stop codons, resulting in truncated p53 and loss of tumor suppressor function. β‐catenin accumulation was observed in tumors with CTNNB1 mutations (D32N/Y, S33C/Y, S34V, S37P, T41A, and S45P). CCND1 expression, a key target of the Wnt/β‐catenin pathway, was significantly upregulated in tumors harboring CTNNB1 and AXIN1 mutations ( p = 0.02213). Statistical analysis revealed a positive correlation between β‐catenin and CCND1 expression levels ( r = 0.42703). Hepatitis virus infections were significantly associated with these mutations ( p < 0.01), suggesting a link between viral infection and genetic alterations in HCC development. Compared to TCGA data, our cohort displayed a significantly higher mutation frequency ( p < 0.001 and p < 0.05), indicating potential regional genetic and environmental influences.

Conclusion

This study provides insights into the molecular mechanisms of HCC in Mongolia, highlighting distinct mutational patterns in TP53 , CTNNB1 , AXIN1 , and KRAS . The association between hepatitis virus infections and these mutations underscores their potential oncogenic impact and may inform future therapeutic strategies for HCC in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAxin ProteinTumor Suppressor Protein p53Janus Kinase 1Humansbeta CateninMaleFemaleMiddle AgedProto-Oncogene Proteins p21(ras)MongoliaMutationAgedAdultMutation Rate

Stichwörter der Autor:innen

hepatocellular carcinomaliver cancermutationp53β‐catenin

Substanzen

Axin Proteinbeta CateninCTNNB1 protein, humanTumor Suppressor Protein p53AXIN1 protein, humanKRAS protein, humanTP53 protein, humanProto-Oncogene Proteins p21(ras)JAK1 protein, humanJanus Kinase 1

Autor:innen und Institutionen

  • Laboratory of Molecular Biology, Institute of Biology, Mongolian Academy of Sciences, Ulaanbaatar, Mongolia.
  • Department of General Surgery, Second State Central Hospital, Ulaanbaatar, Mongolia.

ORCID-Profile: Nomin Bold, Khurelsukh Buyanbat, Ariya Enkhtuya, Nomin Myagmar, Gerelsuren Batbayar, Zolzaya Sandag, Dolgion Damdinbazar, Nomuun Oyunbat, Tuul Boldbaatar, Ankhbayar Enkhbaatar, Gan-Erdene Baatarjav, Taivan Nanzaddorj, Tsendsuren Oyunsuren, Gantulga Davaakhuu

Förderung

  • Mongolian Foundation for Science and Technology

Zitieren

APA

Bold, N., Buyanbat, K., Enkhtuya, A., Myagmar, N., Batbayar, G., Sandag, Z., Damdinbazar, D., Oyunbat, N., Boldbaatar, T., Enkhbaatar, A., Baatarjav, G. E., Nanzaddorj, T., Oyunsuren, T., & Davaakhuu, G. (2025). High‐Frequency Mutations in TP53 , AXIN1 , CTNNB1 , and KRAS , and Polymorphisms in JAK1 Genes Among Mongolian HCC Patients. Cancer Reports. https://doi.org/10.1002/cnr2.70227

Vancouver

Bold N, Buyanbat K, Enkhtuya A, Myagmar N, Batbayar G, Sandag Z, et al. High‐Frequency Mutations in TP53 , AXIN1 , CTNNB1 , and KRAS , and Polymorphisms in JAK1 Genes Among Mongolian HCC Patients. Cancer Reports. 2025. doi:10.1002/cnr2.70227

BibTeX
@article{Bold2025,
  author = {Bold, Nomin and Buyanbat, Khurelsukh and Enkhtuya, Ariya and Myagmar, Nomin and Batbayar, Gerelsuren and Sandag, Zolzaya and Damdinbazar, Dolgion and Oyunbat, Nomuun and Boldbaatar, Tuul and Enkhbaatar, Ankhbayar and Baatarjav, Gan-Erdene and Nanzaddorj, Taivan and Oyunsuren, Tsendsuren and Davaakhuu, Gantulga},
  title = {High‐Frequency Mutations in TP53 , AXIN1 , CTNNB1 , and KRAS , and Polymorphisms in JAK1 Genes Among Mongolian HCC Patients},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70227}
}
Kostenlos starten →